Paricalcitol: A Review of its Use in the Management of Secondary Hyperparathyroidism

Author： Dean M. Robinson   Lesley J. Scott  

Publisher： Adis International

ISSN： 0012-6667

Source： Drugs, Vol.65, Iss.4, 2005-01, pp. : 559-576

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

IV paricalcitol the clear winner in secondary hyperparathyroidism

By  

Inpharma, Vol. 1, Iss. 1568, 2006-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

IV paricalcitol the clear winner in secondary hyperparathyroidism

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 518, 2006-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite

Cinacalcet: A Pharmacoeconomic Review of its Use in Secondary Hyperparathyroidism in End-Stage Renal Disease

By Plosker Greg L.  

PharmacoEconomics, Vol. 29, Iss. 9, 2011-09 ,pp. : 807-821

Adis International

Access to resources Recommend Favorite

Paricalcitol capsules for the control of secondary hyperparathyroidism in chronic kidney disease

By Cheng Steven   Coyne Daniel  

Expert Opinion on Pharmacotherapy, Vol. 7, Iss. 5, 2006-04 ,pp. : 617-621

Informa Healthcare

Access to resources Recommend Favorite

New Perspectives in the Management of Secondary Hyperparathyroidism

By  

Mini Reviews in Medicinal Chemistry, Vol. 7, Iss. 6, 2007-06 ,pp. : 591-598

Bentham Science Publishers

Access to resources Recommend Favorite